Welcome : Guest

Zynerba Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Zynerba Pharmaceuticals, Inc., which is principally involved in Specialty Pharmaceuticals Business. Illustrated with 6 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-66426
Price: $300
Company Type: Public
Pages: 8
Date: November 2016
Market Data Tables: 6

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Epilepsy Drugs......3
Table 1: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......3
Anti-Osteoarthritis......4
Table 2: Anti-Osteoarthritis Market in Korea (2015-2020) in KRW Million......4
Orphan Drugs......5
Table 3: Specialty Pharma & Orphan Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, US and Rest of the World......5
Epilepsy Therapeutics......6
Table 4: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......6
Anti-Osteoarthritis......7
Table 5: Market Shares of Leading Anti-Osteoarthritis Medicine Manufacturers in Korea (2015) - Percentage Breakdown by Value for Humedix Co., Ltd., and Others......7
Orphan Disease Therapeutics......8
Table 6: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......8